A urine cytology test is a diagnostic tool that can help detect different types of cancer in the urinary system. Using the test, a cytopathologist can screen for pre-cancer or cancer cells in urine.

A urine cytology test looks at the cells in your urine under a microscope. It can help your doctor diagnose some forms of urinary tract cancer. You may need one if you've had blood in your urine.

Both alternative tests had higher specificity than the urinary DNA methylation test, with urine cytology achieving 99.5% specificity (95% CI, 99.0–100%) for patients without high-grade or ...

Investigators compared diagnostic accuracy of this approach with that of the NMP22 test and a urine cytology test. The analysis included 1,099 patients (55.9% men) aged older than 39 years ...

SANTA CLARA, Calif., May 30, 2025 /PRNewswire/ -- AIxMed, innovators and providers of an AI-powered computational platform for cytology applications, and CorePlus have entered a Memorandum of ...

Urine samples were collected for DNA methylation, NMP22, and urine cytology tests, and patients underwent cystoscopy. Primary outcomes included sensitivity and specificity for high-grade or ...

Lumea and AIxMed team up to bring AI driven urine cytology to Lumea's platform, targeting improved bladder cancer diagnostics. SANTA CLARA, Calif., May 30, 2025 /PRNewswire/ -- AIxMed, an ...

AIxMed and CorePlus team up to bring AI-driven quality control to improve bladder cancer diagnostics. SANTA CLARA, Calif., May 30, 2025 /PRNewswire/ -- AIxMed, innovators and providers of an AI ...

AIxMed, an innovator in AI diagnostics for urine cytology and Lumea, a leading provider of primary clinical digital pathology solutions, today announced a new partnership. This collaboration will ...

AIxMed's experience in AI-based cytology software and analysis, combined with CorePlus' experience in integrating digital and AI solutions into their day-to-day pathology workflow will come ...